{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T06:52:13Z","timestamp":1793429533892,"version":"4.5.0"},"reference-count":90,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-21-CE18-0025-01 NOVEL"],"award-info":[{"award-number":["ANR-21-CE18-0025-01 NOVEL"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Fondation Maladies Rares grant","award":["No. 10877"],"award-info":[{"award-number":["No. 10877"]}]},{"name":"Fondation pour la Recherche M\u00e9dicale Prix MARIE_PAULE BURRUS 2024","award":["PRS202407019918"],"award-info":[{"award-number":["PRS202407019918"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Parkinsons Dis."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Mutations in the\n                    <jats:italic>ATP13A2<\/jats:italic>\n                    gene were identified as the cause of Kufor-Rakeb syndrome (KRS), a juvenile-onset form of Parkinson\u2019s disease (PD). Developing relevant and predictive models for the rare PD forms is necessary to understand the pathological mechanisms and validate therapeutic strategies. Herein, we aimed to comprehensively characterize the first transgenic\n                    <jats:italic>Atp13a2<\/jats:italic>\n                    knockout rat model. Behavioral assessment demonstrated specific developmental deficits in animals with deletion of\n                    <jats:italic>Atp13a2<\/jats:italic>\n                    . Further analysis revealed that\n                    <jats:italic>Atp13a2<\/jats:italic>\n                    knockout rats displayed age-dependent fine motor skills deficits and impaired locomotor habituation similar to those observed in PD patients at the early stage of motor symptoms. In contrast, no change in the nigrostriatal integrity was observed. An extended investigation on heavy metals homeostasis, autophagy-related markers, and lipofuscin accumulation showed significant changes reminiscent of KRS. Finally, we tested whether inducing pathology by viral-mediated overexpression of human \u03b1-synuclein or human tyrosinase exacerbated the onset or extent of pathological changes. This\n                    <jats:italic>Atp13a2<\/jats:italic>\n                    KO rat model could help better understand autophagy in PD pathogenesis and open new therapeutic validation opportunities.\n                  <\/jats:p>","DOI":"10.1038\/s41531-025-01171-0","type":"journal-article","created":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T13:07:44Z","timestamp":1763471264000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Phenotypic characterization of an Atp13a2 knockout rat model of Parkinson\u2019s disease"],"prefix":"10.1038","volume":"11","author":[{"given":"R\u00e9mi","family":"Kinet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Sikora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Laure","family":"Arotcarena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melina","family":"Decourt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Balado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyne","family":"Doudnikoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvain","family":"Bohic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Vesnaver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Lovisotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Laure","family":"Thiolat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Dutheil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Mazzocco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karim","family":"Harhouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00e9my","family":"Steinschneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Severine","family":"Menoret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Tesson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Anegon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Morari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miquel","family":"Vila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Georges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erwan","family":"Bezard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Olivier","family":"Fernagut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Dehay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,18]]},"reference":[{"key":"1171_CR1","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1136\/jnnp.54.5.388","volume":"54","author":"WR Gibb","year":"1991","unstructured":"Gibb, W. R. & Lees, A. J. Anatomy, pigmentation, ventral and dorsal subpopulations of the substantia nigra, and differential cell death in Parkinson\u2019s disease. J. Neurol. Neurosurg. Psychiatry 54, 388\u2013396 (1991).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"1171_CR2","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak, H. et al. Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol. Aging 24, 197\u2013211 (2003).","journal-title":"Neurobiol. Aging"},{"key":"1171_CR3","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1016\/S1474-4422(24)00378-8","volume":"23","author":"SY Lim","year":"2024","unstructured":"Lim, S. Y. et al. Uncovering the genetic basis of Parkinson\u2019s disease globally: from discoveries to the clinic. Lancet Neurol. 23, 1267\u20131280 (2024).","journal-title":"Lancet Neurol."},{"key":"1171_CR4","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1038\/ng1884","volume":"38","author":"A Ramirez","year":"2006","unstructured":"Ramirez, A. et al. Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase. Nat. Genet. 38, 1184\u20131191 (2006).","journal-title":"Nat. Genet."},{"key":"1171_CR5","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1002\/mds.20511","volume":"20","author":"DR Williams","year":"2005","unstructured":"Williams, D. R., Hadeed, A., al-Din, A. S., Wreikat, A. L. & Lees, A. J. Kufor Rakeb disease: autosomal recessive, levodopa-responsive parkinsonism with pyramidal degeneration, supranuclear gaze palsy, and dementia. Mov. Disord. 20, 1264\u20131271 (2005).","journal-title":"Mov. Disord."},{"key":"1171_CR6","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1111\/j.1600-0404.1994.tb02645.x","volume":"89","author":"Najim al-Din","year":"1994","unstructured":"al-Din, N. ajim, Wriekat, A. S., Mubaidin, A., Dasouki, A. & Hiari, M. M. Pallido-pyramidal degeneration, supranuclear upgaze paresis and dementia: Kufor-Rakeb syndrome. Acta Neurol. Scand. 89, 347\u2013352 (1994).","journal-title":"Acta Neurol. Scand."},{"key":"1171_CR7","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3389\/fnmol.2014.00048","volume":"7","author":"S van Veen","year":"2014","unstructured":"van Veen, S., Holemans, S. orensenD. M., Holen, T., Palmgren, H. W. & Vangheluwe, M. G. Cellular function and pathological role of ATP13A2 and related P-type transport ATPases in Parkinson\u2019s disease and other neurological disorders. Front. Mol. Neurosci. 7, 48 (2014).","journal-title":"Front. Mol. Neurosci."},{"key":"1171_CR8","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1038\/s41586-020-1968-7","volume":"578","author":"S van Veen","year":"2020","unstructured":"van Veen, S. et al. ATP13A2 deficiency disrupts lysosomal polyamine export. Nature 578, 419\u2013424 (2020).","journal-title":"Nature"},{"key":"1171_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-37815-z","volume":"14","author":"T Fujii","year":"2023","unstructured":"Fujii, T. et al. Parkinson\u2019s disease-associated ATP13A2\/PARK9 functions as a lysosomal H(+),K(+)-ATPase. Nat. Commun. 14, 2174 (2023).","journal-title":"Nat. Commun."},{"key":"1171_CR10","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.bbrc.2009.03.151","volume":"383","author":"K Schmidt","year":"2009","unstructured":"Schmidt, K., Wolfe, D. M., Stiller, B. & Pearce, D. A. Cd2+, Mn2+, Ni2+ and Se2+ toxicity to Saccharomyces cerevisiae lacking YPK9p the orthologue of human ATP13A2. Biochem. Biophys. Res. Commun. 383, 198\u2013202 (2009).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"1171_CR11","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1002\/mds.22947","volume":"25","author":"SA Schneider","year":"2010","unstructured":"Schneider, S. A. et al. ATP13A2 mutations (PARK9) cause neurodegeneration with brain iron accumulation. Mov. Disord. 25, 979\u2013984 (2010).","journal-title":"Mov. Disord."},{"key":"1171_CR12","doi-asserted-by":"publisher","first-page":"9611","DOI":"10.1073\/pnas.1112368109","volume":"109","author":"B Dehay","year":"2012","unstructured":"Dehay, B. et al. Loss of P-type ATPase ATP13A2\/PARK9 function induces general lysosomal deficiency and leads to Parkinson disease neurodegeneration. Proc. Natl. Acad. Sci. USA 109, 9611\u20139616 (2012).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1171_CR13","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/ng.300","volume":"41","author":"AD Gitler","year":"2009","unstructured":"Gitler, A. D. et al. Alpha-synuclein is part of a diverse and highly conserved interaction network that includes PARK9 and manganese toxicity. Nat. Genet. 41, 308\u2013315 (2009).","journal-title":"Nat. Genet."},{"key":"1171_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s40246-019-0203-9","volume":"13","author":"R Spataro","year":"2019","unstructured":"Spataro, R. et al. Mutations in ATP13A2 (PARK9) are associated with an amyotrophic lateral sclerosis-like phenotype, implicating this locus in further phenotypic expansion. Hum. Genomics 13, 19 (2019).","journal-title":"Hum. Genomics"},{"key":"1171_CR15","doi-asserted-by":"publisher","first-page":"1252400","DOI":"10.3389\/fneur.2023.1252400","volume":"14","author":"KM Croucher","year":"2023","unstructured":"Croucher, K. M. & Fleming, S. M. ATP13A2 (PARK9) and basal ganglia function. Front. Neurol. 14, 1252400 (2023).","journal-title":"Front. Neurol."},{"key":"1171_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.615491","volume":"12","author":"V Chenouard","year":"2021","unstructured":"Chenouard, V. et al. Advances in genome editing and application to the generation of genetically modified rat models. Front. Genet. 12, 615491 (2021).","journal-title":"Front. Genet."},{"key":"1171_CR17","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s12035-014-8927-y","volume":"53","author":"LM Villeneuve","year":"2016","unstructured":"Villeneuve, L. M., Purnell, P. R., Boska, M. D. & Fox, H. S. Early expression of Parkinson\u2019s disease-related mitochondrial abnorMALITIes in PINK1 knockout rats. Mol. Neurobiol. 53, 171\u2013186 (2016).","journal-title":"Mol. Neurobiol."},{"key":"1171_CR18","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.nbd.2014.06.009","volume":"70","author":"KD Dave","year":"2014","unstructured":"Dave, K. D. et al. Phenotypic characterization of recessive gene knockout rat models of Parkinson\u2019s disease. Neurobiol. Dis. 70, 190\u2013203 (2014).","journal-title":"Neurobiol. Dis."},{"key":"1171_CR19","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.dib.2016.09.031","volume":"9","author":"KL Stauch","year":"2016","unstructured":"Stauch, K. L. et al. SWATH-MS proteome profiling data comparison of DJ-1, Parkin, and PINK1 knockout rat striatal mitochondria. Data Brief. 9, 589\u2013593 (2016).","journal-title":"Data Brief."},{"key":"1171_CR20","doi-asserted-by":"publisher","first-page":"e66164","DOI":"10.1371\/journal.pone.0066164","volume":"8","author":"D Ness","year":"2013","unstructured":"Ness, D. et al. Leucine-rich repeat kinase 2 (LRRK2)-deficient rats exhibit renal tubule injury and perturbations in metabolic and immunological homeostasis. PLoS ONE 8, e66164 (2013).","journal-title":"PLoS ONE"},{"key":"1171_CR21","doi-asserted-by":"publisher","first-page":"e80705","DOI":"10.1371\/journal.pone.0080705","volume":"8","author":"MA Baptista","year":"2013","unstructured":"Baptista, M. A. et al. Loss of leucine-rich repeat kinase 2 (LRRK2) in rats leads to progressive abnormal phenotypes in peripheral organs. PLoS One 8, e80705 (2013).","journal-title":"PLoS One"},{"key":"1171_CR22","doi-asserted-by":"publisher","DOI":"10.1042\/NS20220040","volume":"7","author":"C Domenicale","year":"2023","unstructured":"Domenicale, C., Magnabosco, S. & Morari, M. Modeling Parkinson\u2019s disease in LRRK2 rodents. Neuronal Signal 7, NS20220040 (2023).","journal-title":"Neuronal Signal"},{"key":"1171_CR23","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1002\/cne.23583","volume":"522","author":"AB West","year":"2014","unstructured":"West, A. B. et al. Differential LRRK2 expression in the cortex, striatum, and substantia nigra in transgenic and nontransgenic rodents. J. Comp. Neurol. 522, 2465\u20132480 (2014).","journal-title":"J. Comp. Neurol."},{"key":"1171_CR24","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.nbd.2011.12.013","volume":"45","author":"M Decressac","year":"2012","unstructured":"Decressac, M., Mattsson, B., Lundblad, M., Weikop, P. & Bjorklund, A. Progressive neurodegenerative and behavioural changes induced by AAV-mediated overexpression of alpha-synuclein in midbrain dopamine neurons. Neurobiol. Dis. 45, 939\u2013953 (2012).","journal-title":"Neurobiol. Dis."},{"key":"1171_CR25","doi-asserted-by":"publisher","first-page":"e17698","DOI":"10.1371\/journal.pone.0017698","volume":"6","author":"JB Koprich","year":"2011","unstructured":"Koprich, J. B. et al. Progressive neurodegeneration or endogenous compensation in an animal model of Parkinson\u2019s disease produced by decreasing doses of alpha-synuclein. PLoS One 6, e17698 (2011).","journal-title":"PLoS One"},{"key":"1171_CR26","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1016\/j.neurobiolaging.2014.11.015","volume":"36","author":"A Van der Perren","year":"2015","unstructured":"Van der Perren, A. et al. Longitudinal follow-up and characterization of a robust rat model for Parkinson\u2019s disease based on overexpression of alpha-synuclein with adeno-associated viral vectors. Neurobiol. Aging 36, 1543\u20131558 (2015).","journal-title":"Neurobiol. Aging"},{"key":"1171_CR27","volume":"2011","author":"F Lelan","year":"2011","unstructured":"Lelan, F. et al. Effects of human alpha-synuclein A53T-A30P mutations on SVZ and local olfactory bulb cell proliferation in a transgenic rat model of parkinson disease. Parkinsons Dis. 2011, 987084 (2011).","journal-title":"Parkinsons Dis."},{"key":"1171_CR28","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.expneurol.2012.11.007","volume":"240","author":"JR Cannon","year":"2013","unstructured":"Cannon, J. R. et al. Expression of human E46K-mutated alpha-synuclein in BAC-transgenic rats replicates early-stage Parkinson\u2019s disease features and enhances vulnerability to mitochondrial impairment. Exp. Neurol. 240, 44\u201356 (2013).","journal-title":"Exp. Neurol."},{"key":"1171_CR29","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1002\/mds.27296","volume":"33","author":"RB Creed","year":"2018","unstructured":"Creed, R. B. & Goldberg, M. S. New developments in genetic rat models of Parkinson\u2019s disease. Mov. Disord. 33, 717\u2013729 (2018).","journal-title":"Mov. Disord."},{"key":"1171_CR30","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1093\/hmg\/ddt057","volume":"22","author":"PJ Schultheis","year":"2013","unstructured":"Schultheis, P. J. et al. Atp13a2-deficient mice exhibit neuronal ceroid lipofuscinosis, limited alpha-synuclein accumulation and age-dependent sensorimotor deficits. Hum. Mol. Genet. 22, 2067\u20132082 (2013).","journal-title":"Hum. Mol. Genet."},{"key":"1171_CR31","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41531-024-00748-5","volume":"10","author":"ML Erb","year":"2024","unstructured":"Erb, M. L., Sipple, K., Levine, N., Chen, X. & Moore, D. J. Adult-onset deletion of ATP13A2 in mice induces progressive nigrostriatal pathway dopaminergic degeneration and lysosomal abnormalities. NPJ Parkinsons Dis. 10, 133 (2024).","journal-title":"NPJ Parkinsons Dis."},{"key":"1171_CR32","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41531-024-00757-4","volume":"10","author":"J Sikora","year":"2024","unstructured":"Sikora, J. et al. Nigral ATP13A2 depletion induces Parkinson\u2019s disease-related neurodegeneration in a pilot study in non-human primates. NPJ Parkinsons Dis. 10, 141 (2024).","journal-title":"NPJ Parkinsons Dis."},{"key":"1171_CR33","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/s41531-024-00814-y","volume":"10","author":"V Baekelandt","year":"2024","unstructured":"Baekelandt, V. Depletion of ATP13A2 in adult brain induces a Parkinsonian phenotype in mice and non-human primates. NPJ Parkinsons Dis. 10, 193 (2024).","journal-title":"NPJ Parkinsons Dis."},{"key":"1171_CR34","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s10048-024-00767-7","volume":"25","author":"MA Colijn","year":"2024","unstructured":"Colijn, M. A. et al. Kufor-Rakeb syndrome-associated psychosis: a novel loss-of-function ATP13A2 variant and response to antipsychotic therapy. Neurogenetics 25, 405\u2013415 (2024).","journal-title":"Neurogenetics"},{"key":"1171_CR35","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1016\/S1474-4422(09)70238-8","volume":"8","author":"DW Dickson","year":"2009","unstructured":"Dickson, D. W. et al. Neuropathological assessment of Parkinson\u2019s disease: refining the diagnostic criteria. Lancet Neurol. 8, 1150\u20131157 (2009).","journal-title":"Lancet Neurol."},{"key":"1171_CR36","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","volume":"386","author":"LV Kalia","year":"2015","unstructured":"Kalia, L. V. & Lang, A. E. Parkinson\u2019s disease. Lancet 386, 896\u2013912 (2015).","journal-title":"Lancet"},{"key":"1171_CR37","doi-asserted-by":"publisher","first-page":"3723","DOI":"10.1007\/s10072-023-06899-2","volume":"44","author":"S Satolli","year":"2023","unstructured":"Satolli, S., Di Fonzo, A., Zanobio, M., Pezzullo, G. & De Micco, R. Kufor Rakeb syndrome without gaze palsy and pyramidal signs due to novel ATP13A2 mutations. Neurol. Sci. 44, 3723\u20133725 (2023).","journal-title":"Neurol. Sci."},{"key":"1171_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2020.104786","volume":"139","author":"N Anand","year":"2020","unstructured":"Anand, N. et al. Dysregulated iron metabolism in C. elegans catp-6\/ATP13A2 mutant impairs mitochondrial function. Neurobiol. Dis. 139, 104786 (2020).","journal-title":"Neurobiol. Dis."},{"key":"1171_CR39","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.neuro.2017.06.005","volume":"64","author":"SM Fleming","year":"2018","unstructured":"Fleming, S. M. et al. The effect of manganese exposure in Atp13a2-deficient mice. Neurotoxicology 64, 256\u2013266 (2018).","journal-title":"Neurotoxicology"},{"key":"1171_CR40","doi-asserted-by":"publisher","first-page":"2802","DOI":"10.1093\/hmg\/ddt623","volume":"23","author":"JS Park","year":"2014","unstructured":"Park, J. S., Koentjoro, B., Veivers, D., Mackay-Sim, A. & Sue, C. M. Parkinson\u2019s disease-associated human ATP13A2 (PARK9) deficiency causes zinc dyshomeostasis and mitochondrial dysfunction. Hum. Mol. Genet. 23, 2802\u20132815 (2014).","journal-title":"Hum. Mol. Genet."},{"key":"1171_CR41","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1523\/JNEUROSCI.3117-15.2016","volume":"36","author":"S Rajagopalan","year":"2016","unstructured":"Rajagopalan, S., Rane, A., Chinta, S. J. & Andersen, J. K. Regulation of ATP13A2 via PHD2-HIF1alpha signaling is critical for cellular iron homeostasis: implications for Parkinson\u2019s disease. J. Neurosci. 36, 1086\u20131095 (2016).","journal-title":"J. Neurosci."},{"key":"1171_CR42","doi-asserted-by":"publisher","first-page":"29654","DOI":"10.1074\/jbc.M111.233874","volume":"286","author":"J Tan","year":"2011","unstructured":"Tan, J. et al. Regulation of intracellular manganese homeostasis by Kufor-Rakeb syndrome-associated ATP13A2 protein. J. Biol. Chem. 286, 29654\u201329662 (2011).","journal-title":"J. Biol. Chem."},{"key":"1171_CR43","doi-asserted-by":"publisher","first-page":"2791","DOI":"10.1093\/hmg\/ddt572","volume":"23","author":"T Tsunemi","year":"2014","unstructured":"Tsunemi, T. & Krainc, D. Zn(2)(+) dyshomeostasis caused by loss of ATP13A2\/PARK9 leads to lysosomal dysfunction and alpha-synuclein accumulation. Hum. Mol. Genet. 23, 2791\u20132801 (2014).","journal-title":"Hum. Mol. Genet."},{"key":"1171_CR44","doi-asserted-by":"publisher","first-page":"4240","DOI":"10.1523\/JNEUROSCI.5575-11.2012","volume":"32","author":"M Usenovic","year":"2012","unstructured":"Usenovic, M., Tresse, E., Mazzulli, J. R., Taylor, J. P. & Krainc, D. Deficiency of ATP13A2 leads to lysosomal dysfunction, alpha-synuclein accumulation, and neurotoxicity. J. Neurosci. 32, 4240\u20134246 (2012).","journal-title":"J. Neurosci."},{"key":"1171_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2013.421","volume":"4","author":"K Castillo","year":"2013","unstructured":"Castillo, K. et al. Measurement of autophagy flux in the nervous system in vivo. Cell Death Dis. 4, e917 (2013).","journal-title":"Cell Death Dis."},{"key":"1171_CR46","doi-asserted-by":"publisher","first-page":"e9283","DOI":"10.15252\/emmm.201809283","volume":"11","author":"P Bonsi","year":"2019","unstructured":"Bonsi, P. et al. RGS9-2 rescues dopamine D2 receptor levels and signaling in DYT1 dystonia mouse models. EMBO Mol. Med. 11, e9283 (2019).","journal-title":"EMBO Mol. Med."},{"key":"1171_CR47","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1212\/WNL.0000000000012705","volume":"97","author":"HF Chien","year":"2021","unstructured":"Chien, H. F. et al. Neuropathologic findings in a patient with juvenile-onset levodopa-responsive Parkinsonism due to ATP13A2 mutation. Neurology 97, 763\u2013766 (2021).","journal-title":"Neurology"},{"key":"1171_CR48","doi-asserted-by":"publisher","first-page":"2816","DOI":"10.1093\/hmg\/ddu099","volume":"23","author":"SM Kong","year":"2014","unstructured":"Kong, S. M. et al. Parkinson\u2019s disease-linked human PARK9\/ATP13A2 maintains zinc homeostasis and promotes alpha-Synuclein externalization via exosomes. Hum. Mol. Genet. 23, 2816\u20132833 (2014).","journal-title":"Hum. Mol. Genet."},{"key":"1171_CR49","doi-asserted-by":"publisher","first-page":"e129719","DOI":"10.1172\/jci.insight.129719","volume":"4","author":"ML Arotcarena","year":"2019","unstructured":"Arotcarena, M. L. et al. Transcription factor EB overexpression prevents neurodegeneration in experimental synucleinopathies. JCI Insight 4, e129719 (2019).","journal-title":"JCI Insight"},{"key":"1171_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-07181-0","volume":"7","author":"S Bido","year":"2017","unstructured":"Bido, S., Soria, F. N., Fan, R. Z., Bezard, E. & Tieu, K. Mitochondrial division inhibitor-1 is neuroprotective in the A53T-alpha-synuclein rat model of Parkinson\u2019s disease. Sci. Rep. 7, 7495 (2017).","journal-title":"Sci. Rep."},{"key":"1171_CR51","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s40478-015-0222-2","volume":"3","author":"M Bourdenx","year":"2015","unstructured":"Bourdenx, M. et al. Lack of additive role of ageing in nigrostriatal neurodegeneration triggered by alpha-synuclein overexpression. Acta Neuropathol. Commun. 3, 46 (2015).","journal-title":"Acta Neuropathol. Commun."},{"key":"1171_CR52","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.nbd.2018.08.018","volume":"120","author":"S Novello","year":"2018","unstructured":"Novello, S. et al. G2019S LRRK2 mutation facilitates alpha-synuclein neuropathology in aged mice. Neurobiol. Dis. 120, 21\u201333 (2018).","journal-title":"Neurobiol. Dis."},{"key":"1171_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-08858-y","volume":"10","author":"I Carballo-Carbajal","year":"2019","unstructured":"Carballo-Carbajal, I. et al. Brain tyrosinase overexpression implicates age-dependent neuromelanin production in Parkinson\u2019s disease pathogenesis. Nat. Commun. 10, 973 (2019).","journal-title":"Nat. Commun."},{"key":"1171_CR54","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1002\/mdc3.13933","volume":"11","author":"E Amini","year":"2024","unstructured":"Amini, E. et al. Estimation of ambulation and survival in neurodegeneration with brain iron accumulation disorders. Mov. Disord. Clin. Pract. 11, 53\u201362 (2024).","journal-title":"Mov. Disord. Clin. Pract."},{"key":"1171_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2020.147167","volume":"1750","author":"K Kirimtay","year":"2021","unstructured":"Kirimtay, K., Temizci, B., Gultekin, M., Yapici, Z. & Karabay, A. Novel mutations in ATP13A2 associated with mixed neurological presentations and iron toxicity due to nonsense-mediated decay. Brain Res. 1750, 147167 (2021).","journal-title":"Brain Res."},{"key":"1171_CR56","doi-asserted-by":"publisher","first-page":"5724","DOI":"10.1523\/JNEUROSCI.0632-14.2015","volume":"35","author":"LR Kett","year":"2015","unstructured":"Kett, L. R. et al. alpha-Synuclein-independent histopathological and motor deficits in mice lacking the endolysosomal Parkinsonism protein Atp13a2. J. Neurosci. 35, 5724\u20135742 (2015).","journal-title":"J. Neurosci."},{"key":"1171_CR57","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.neuroscience.2019.04.033","volume":"409","author":"RB Creed","year":"2019","unstructured":"Creed, R. B. et al. Basal and Evoked Neurotransmitter Levels in Parkin, DJ-1, PINK1 and LRRK2 Knockout Rat Striatum. Neuroscience 409, 169\u2013179 (2019).","journal-title":"Neuroscience"},{"key":"1171_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2020.105246","volume":"150","author":"RB Creed","year":"2021","unstructured":"Creed, R. B., Roberts, R. C., Farmer, C. B., McMahon, L. L. & Goldberg, M. S. Increased glutamate transmission onto dorsal striatum spiny projection neurons in Pink1 knockout rats. Neurobiol. Dis. 150, 105246 (2021).","journal-title":"Neurobiol. Dis."},{"key":"1171_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2024.106701","volume":"202","author":"CM Massari","year":"2024","unstructured":"Massari, C. M. et al. Neuropathology in an alpha-synuclein preformed fibril mouse model occurs independent of the Parkinson\u2019s disease-linked lysosomal ATP13A2 protein. Neurobiol. Dis. 202, 106701 (2024).","journal-title":"Neurobiol. Dis."},{"key":"1171_CR60","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1093\/brain\/114.4.1953","volume":"114","author":"DT Dexter","year":"1991","unstructured":"Dexter, D. T. et al. Alterations in the levels of iron, ferritin and other trace metals in Parkinson\u2019s disease and other neurodegenerative diseases affecting the basal ganglia. Brain 114, 1953\u20131975 (1991).","journal-title":"Brain"},{"key":"1171_CR61","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jns.2011.01.003","volume":"303","author":"I Hozumi","year":"2011","unstructured":"Hozumi, I. et al. Patterns of levels of biological metals in CSF differ among neurodegenerative diseases. J. Neurol. Sci. 303, 95\u201399 (2011).","journal-title":"J. Neurol. Sci."},{"key":"1171_CR62","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/0022-510X(92)90127-7","volume":"112","author":"FJ Jimenez-Jimenez","year":"1992","unstructured":"Jimenez-Jimenez, F. J. et al. Serum levels of zinc and copper in patients with Parkinson\u2019s disease. J. Neurol. Sci. 112, 30\u201333 (1992).","journal-title":"J. Neurol. Sci."},{"key":"1171_CR63","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1111\/j.1471-4159.1989.tb07264.x","volume":"52","author":"DT Dexter","year":"1989","unstructured":"Dexter, D. T. et al. Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson\u2019s disease. J. Neurochem. 52, 1830\u20131836 (1989).","journal-title":"J. Neurochem."},{"key":"1171_CR64","doi-asserted-by":"crossref","unstructured":"Gao H. et al. ATP13A2 declines zinc-induced accumulation of alpha-synuclein in a Parkinson\u2019s disease model. Int. J. Mol. Sci. 23, 8035 (2022)","DOI":"10.3390\/ijms23148035"},{"key":"1171_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2025.116179","volume":"44","author":"M Samaddar","year":"2025","unstructured":"Samaddar, M. et al. Lysosomal polyamine storage upon ATP13A2 loss impairs beta-glucocerebrosidase via altered lysosomal pH and electrostatic hydrolase-lipid interactions. Cell Rep. 44, 116179 (2025).","journal-title":"Cell Rep."},{"key":"1171_CR66","doi-asserted-by":"publisher","first-page":"987","DOI":"10.4161\/auto.20256","volume":"8","author":"M Usenovic","year":"2012","unstructured":"Usenovic, M. & Krainc, D. Lysosomal dysfunction in neurodegeneration: the role of ATP13A2\/PARK9. Autophagy 8, 987\u2013988 (2012).","journal-title":"Autophagy"},{"key":"1171_CR67","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2024.1357347","volume":"16","author":"C Sagheddu","year":"2024","unstructured":"Sagheddu, C. et al. Cognitive performance in aged rats is associated with differences in distinctive neuronal populations in the ventral tegmental area and altered synaptic plasticity in the hippocampus. Front Aging Neurosci. 16, 1357347 (2024).","journal-title":"Front Aging Neurosci."},{"key":"1171_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2022.105465","volume":"162","author":"XY Chen","year":"2023","unstructured":"Chen, X. Y., Liu, C., Xue, Y. & Chen, L. Changed firing activity of nigra dopaminergic neurons in Parkinson\u2019s disease. Neurochem. Int. 162, 105465 (2023).","journal-title":"Neurochem. Int."},{"key":"1171_CR69","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3389\/fnagi.2020.00049","volume":"12","author":"VL Tryon","year":"2020","unstructured":"Tryon, V. L., Baker, P. M., Long, J. M., Rapp, P. R. & Mizumori, S. J. Y. Loss of sensitivity to rewards by dopamine neurons may underlie age-related increased probability discounting. Front. Aging Neurosci. 12, 49 (2020).","journal-title":"Front. Aging Neurosci."},{"key":"1171_CR70","doi-asserted-by":"publisher","first-page":"e34178","DOI":"10.1371\/journal.pone.0034178","volume":"7","author":"A Chesi","year":"2012","unstructured":"Chesi, A., Kilaru, A., Fang, X., Cooper, A. A. & Gitler, A. D. The role of the Parkinson\u2019s disease gene PARK9 in essential cellular pathways and the manganese homeostasis network in yeast. PLoS One 7, e34178 (2012).","journal-title":"PLoS One"},{"key":"1171_CR71","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcz019","volume":"1","author":"U Heins-Marroquin","year":"2019","unstructured":"Heins-Marroquin, U., Jung, P. P., Cordero-Maldonado, M. L., Crawford, A. D. & Linster, C. L. Phenotypic assays in yeast and zebrafish reveal drugs that rescue ATP13A2 deficiency. Brain Commun. 1, fcz019 (2019).","journal-title":"Brain Commun."},{"key":"1171_CR72","doi-asserted-by":"publisher","first-page":"7030","DOI":"10.3390\/ijms26157030","volume":"26","author":"K Croucher","year":"2025","unstructured":"Croucher, K. et al. Phenotype differences between ATP13A2 heterozygous and knockout mice across aging. Int. J. Mol. Sci. 26, 7030 (2025).","journal-title":"Int. J. Mol. Sci."},{"key":"1171_CR73","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.bbr.2018.01.029","volume":"343","author":"ER Dirr","year":"2018","unstructured":"Dirr, E. R. et al. Exacerbation of sensorimotor dysfunction in mice deficient in Atp13a2 and overexpressing human wildtype alpha-synuclein. Behav. Brain Res. 343, 41\u201349 (2018).","journal-title":"Behav. Brain Res."},{"key":"1171_CR74","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1002\/mdc3.12570","volume":"5","author":"M Rohani","year":"2018","unstructured":"Rohani, M. et al. Action myoclonus and seizure in Kufor-Rakeb syndrome. Mov. Disord. Clin. Pract. 5, 195\u2013199 (2018).","journal-title":"Mov. Disord. Clin. Pract."},{"key":"1171_CR75","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1001\/archneurol.2010.281","volume":"67","author":"N Bruggemann","year":"2010","unstructured":"Bruggemann, N. et al. Recessively inherited parkinsonism: effect of ATP13A2 mutations on the clinical and neuroimaging phenotype. Arch. Neurol. 67, 1357\u20131363 (2010).","journal-title":"Arch. Neurol."},{"key":"1171_CR76","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1002\/mdc3.13034","volume":"7","author":"B Balint","year":"2020","unstructured":"Balint, B. et al. Psychiatric manifestations of ATP13A2 mutations. Mov. Disord. Clin. Pract. 7, 838\u2013841 (2020).","journal-title":"Mov. Disord. Clin. Pract."},{"key":"1171_CR77","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.mcn.2018.05.009","volume":"92","author":"S Rayaprolu","year":"2018","unstructured":"Rayaprolu, S. et al. Partial loss of ATP13A2 causes selective gliosis independent of robust lipofuscinosis. Mol. Cell Neurosci. 92, 17\u201326 (2018).","journal-title":"Mol. Cell Neurosci."},{"key":"1171_CR78","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-16328-y","volume":"7","author":"S Remy","year":"2017","unstructured":"Remy, S. et al. Generation of gene-edited rats by delivery of CRISPR\/Cas9 protein and donor DNA into intact zygotes using electroporation. Sci. Rep. 7, 16554 (2017).","journal-title":"Sci. Rep."},{"key":"1171_CR79","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/0003-2697(87)90021-2","volume":"162","author":"P Chomczynski","year":"1987","unstructured":"Chomczynski, P. & Sacchi, N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156\u2013159 (1987).","journal-title":"Anal. Biochem."},{"key":"1171_CR80","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1373\/clinchem.2008.112797","volume":"55","author":"SA Bustin","year":"2009","unstructured":"Bustin, S. A. et al. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin. Chem. 55, 611\u2013622 (2009).","journal-title":"Clin. Chem."},{"key":"1171_CR81","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25, 402\u2013408 (2001).","journal-title":"Methods"},{"key":"1171_CR82","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/978-1-60327-389-3_24","volume":"597","author":"YK Urbach","year":"2010","unstructured":"Urbach, Y. K., Bode, F. J., Nguyen, H. P., Riess, O. & von Horsten, S. Neurobehavioral tests in rat models of degenerative brain diseases. Methods Mol. Biol. 597, 333\u2013356 (2010).","journal-title":"Methods Mol. Biol."},{"key":"1171_CR83","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1111\/j.1749-6632.1988.tb42096.x","volume":"537","author":"AA Grace","year":"1988","unstructured":"Grace, A. A. In vivo and in vitro intracellular recordings from rat midbrain dopamine neurons. Ann. N. Y Acad. Sci. 537, 51\u201376 (1988).","journal-title":"Ann. N. Y Acad. Sci."},{"key":"1171_CR84","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/j.neuron.2006.05.007","volume":"50","author":"M Mameli-Engvall","year":"2006","unstructured":"Mameli-Engvall, M. et al. Hierarchical control of dopamine neuron-firing patterns by nicotinic receptors. Neuron 50, 911\u2013921 (2006).","journal-title":"Neuron"},{"key":"1171_CR85","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1038\/nn.2528","volume":"13","author":"M Martinez-Vicente","year":"2010","unstructured":"Martinez-Vicente, M. et al. Cargo recognition failure is responsible for inefficient autophagy in Huntington\u2019s disease. Nat. Neurosci. 13, 567\u2013576 (2010).","journal-title":"Nat. Neurosci."},{"key":"1171_CR86","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1083\/jcb.200505082","volume":"171","author":"WH Yu","year":"2005","unstructured":"Yu, W. H. et al. Macroautophagy-a novel Beta-amyloid peptide-generating pathway activated in Alzheimer\u2019s disease. J. Cell Biol. 171, 87\u201398 (2005).","journal-title":"J. Cell Biol."},{"key":"1171_CR87","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1021\/acschemneuro.0c00751","volume":"12","author":"EG Lavigne","year":"2021","unstructured":"Lavigne, E. G., Buttigieg, D., Steinschneider, R. & Burstein, E. S. Pimavanserin promotes trophic factor release and protects cultured primary dopaminergic neurons exposed to MPP+ in a GDNF-dependent manner. ACS Chem. Neurosci. 12, 2088\u20132098 (2021).","journal-title":"ACS Chem. Neurosci."},{"key":"1171_CR88","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.sab.2006.12.002","volume":"62","author":"VA Sol\u00e9","year":"2007","unstructured":"Sol\u00e9, V. A., Papillon, E., Cotte, M., Walter, P. & Susini, J. A multiplatform code for the analysis of energy-dispersive X-ray fluorescence spectra. Spectrochim. Acta Part B. Spectrosc. 62, 63\u201368 (2007).","journal-title":"Spectrochim. Acta Part B. Spectrosc."},{"key":"1171_CR89","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2020.108006","volume":"167","author":"CA Pisano","year":"2020","unstructured":"Pisano, C. A. et al. Safinamide inhibits in vivo glutamate release in a rat model of Parkinson\u2019s disease. Neuropharmacology 167, 108006 (2020).","journal-title":"Neuropharmacology"},{"key":"1171_CR90","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aaz9165","volume":"6","author":"M Bourdenx","year":"2020","unstructured":"Bourdenx, M. et al. Identification of distinct pathological signatures induced by patient-derived alpha-synuclein structures in nonhuman primates. Sci. Adv. 6, eaaz9165 (2020).","journal-title":"Sci. Adv."}],"container-title":["npj Parkinson's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41531-025-01171-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-025-01171-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-025-01171-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T01:04:17Z","timestamp":1763514257000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41531-025-01171-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,18]]},"references-count":90,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1171"],"URL":"https:\/\/doi.org\/10.1038\/s41531-025-01171-0","relation":{},"ISSN":["2373-8057"],"issn-type":[{"value":"2373-8057","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,18]]},"assertion":[{"value":"11 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"E.B. is a director and shareholder of Motac Neuroscience Ltd. The other authors declare no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"321"}}